TABLE 2.
Results of Linear Mixed Models (n = 70)
| Time | Interaction Time*Treatment | ||||||
|---|---|---|---|---|---|---|---|
| β | 95% CI | P | β | 95% CI | P | ||
| Clinical disease activity | |||||||
| Within group | CBT | –0.006 | –0.052 to 0.040 | 0.80 | |||
| CAU | 0.012 | –0.036 to 0.061 | 0.61 | ||||
| Between groups | –0.019 | –0.085 to 0.048 | 0.59 | ||||
| C-reactive protein, mg/dL | |||||||
| Within group | CBT | –0.015 | –0.050 to 0.020 | 0.41 | |||
| CAU | 0.021 | –0.015 to 0.057 | 0.24 | ||||
| Between groups | –0.036 | –0.086 to 0.014 | 0.158 | ||||
| Fecal calprotectin, µg/g | |||||||
| Within group | CBT | –0.019 | –0.075 to 0.037 | 0.50 | |||
| CAU | 0.005 | –0.052 to 0.063 | 0.851 | ||||
| Between groups | –0.025 | –0.11 to 0.056 | 0.543 |
“Within group” displays whether there was a significant (P < 0.05) change over time within either the CBT or the CAU group. “Between group” reflects whether the course over time was significantly different between the CAU and CBT group (P interaction time*treatment < 0.05).